|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, UTHSCSA, San Antonio, Texas, United States
2 School of Medicine Lake Union, University of Washington, Seattle, Washington, United States
* To whom correspondence should be addressed. E-mail: feliers{at}uthscsa.edu.
Angiotensin II (Ang II) rapidly increases VEGF synthesis in proximal tubular epithelial cells through mRNA translation. The role of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in Ang II regulation of VEGF mRNA translation initiation was examined. Ang II activated hnRNP K as judged by binding to poly(C)- and poly(U)-agarose. Ang II increased hnRNP K binding to VEGF mRNA at the same time as it stimulated its translation, suggesting that hnRNP K contributes to VEGF mRNA translation. Inhibition of hnRNP K expression by RNA interference significantly reduced Ang II stimulation of VEGF synthesis. Ang II increased hnRNP K phosphorylation on both tyrosine and serine residues with distinct time-courses; only Ser302 phosphorylation paralleled binding to VEGF mRNA. Src inhibition using PP2 or RNA interference inhibited PKC
activity and prevented hnRNP K phosphorylation on both tyrosine and serine residues and its binding to VEGF mRNA. Under these conditions, Ang II-induced VEGF synthesis was inhibited. Ang II treatment induced redistribution of both VEGF mRNA and hnRNP K protein from light to heavy polysomal fractions, suggesting increased binding of hnRNP K to VEGF mRNA that is targeted for increased translation. This study shows that hnRNP K augments efficiency of VEGF mRNA translation stimulated by Ang II.
This article has been cited by other articles:
![]() |
B. S. Kasinath, D. Feliers, K. Sataranatarajan, G. Ghosh Choudhury, M. J. Lee, and M. M. Mariappan Regulation of mRNA translation in renal physiology and disease Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1153 - F1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. RamachandraRao, Y. Zhu, T. Ravasi, T. A. McGowan, I. Toh, S. R. Dunn, S. Okada, M. A. Shaw, and K. Sharma Pirfenidone Is Renoprotective in Diabetic Kidney Disease J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1765 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet Role and Therapeutic Potential of VEGF in the Nervous System Physiol Rev, April 1, 2009; 89(2): 607 - 648. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |